Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-β A [Corrigendum] Zheng Y, Gao Y, Li X, et al. Onco Targets Ther. 2018; 11:4965-4977. On page 4972, the authors found an error in which the images for Figure 4A PC3 Blank and Figure 4B 22RV1 Blank were mistakenly duplicated. Upon realising the error, the authors repeated the knockdown experiment described in Figure 4 and were able to show results consistent with those described in the original article. The authors provided a description of the experiment procedure used for the relative colony counts and the raw data from both the original and repeated experiments used to generate the results shown in Figure 4A and Figure 4B . See revised Figure 4 below.
The authors and the editor have confirmed that the correction of the images has no significant impact on the conclusions of the study.
The authors wish to apologise for this error. 
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